CS200536B2 - Method of producing epimeric 4-amino oleandomycin derivatives - Google Patents

Method of producing epimeric 4-amino oleandomycin derivatives Download PDF

Info

Publication number
CS200536B2
CS200536B2 CS78291A CS29178A CS200536B2 CS 200536 B2 CS200536 B2 CS 200536B2 CS 78291 A CS78291 A CS 78291A CS 29178 A CS29178 A CS 29178A CS 200536 B2 CS200536 B2 CS 200536B2
Authority
CS
Czechoslovakia
Prior art keywords
singlet
deoxy
ethyl acetate
acetyl
product
Prior art date
Application number
CS78291A
Other languages
Czech (cs)
English (en)
Inventor
Frank Ch Sciavolino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS200536B2 publication Critical patent/CS200536B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS78291A 1977-02-04 1978-01-16 Method of producing epimeric 4-amino oleandomycin derivatives CS200536B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/765,486 US4125705A (en) 1977-02-04 1977-02-04 Semi-synthetic 4-amino-oleandomycin derivatives

Publications (1)

Publication Number Publication Date
CS200536B2 true CS200536B2 (en) 1980-09-15

Family

ID=25073683

Family Applications (3)

Application Number Title Priority Date Filing Date
CS787693A CS200537B2 (en) 1977-02-04 1978-01-16 Method of producing epimeric 4-amino oleandomycin derivatives
CS787694A CS200538B2 (en) 1977-02-04 1978-01-16 Method of producing derivatives of oleandomycin
CS78291A CS200536B2 (en) 1977-02-04 1978-01-16 Method of producing epimeric 4-amino oleandomycin derivatives

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CS787693A CS200537B2 (en) 1977-02-04 1978-01-16 Method of producing epimeric 4-amino oleandomycin derivatives
CS787694A CS200538B2 (en) 1977-02-04 1978-01-16 Method of producing derivatives of oleandomycin

Country Status (34)

Country Link
US (1) US4125705A (ja)
JP (2) JPS5398981A (ja)
AR (1) AR215666A1 (ja)
AT (1) AT358169B (ja)
AU (1) AU502293B1 (ja)
BE (1) BE863618A (ja)
BG (2) BG32117A4 (ja)
CA (1) CA1106366A (ja)
CH (1) CH629821A5 (ja)
CS (3) CS200537B2 (ja)
DD (1) DD134523A5 (ja)
DE (1) DE2804509C2 (ja)
DK (1) DK149628C (ja)
ES (1) ES465322A1 (ja)
FI (1) FI65262C (ja)
FR (2) FR2383964A1 (ja)
GB (1) GB1583921A (ja)
GR (1) GR68692B (ja)
HU (2) HU179744B (ja)
IE (1) IE46395B1 (ja)
IL (2) IL53959A0 (ja)
IT (1) IT1094211B (ja)
LU (1) LU79007A1 (ja)
NL (1) NL175997C (ja)
NO (2) NO145955C (ja)
NZ (1) NZ186384A (ja)
PH (2) PH14836A (ja)
PL (3) PL110793B1 (ja)
PT (1) PT67569B (ja)
RO (3) RO75387A (ja)
SE (2) SE445222B (ja)
SU (3) SU805949A3 (ja)
YU (3) YU39504B (ja)
ZA (1) ZA78646B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4124755A (en) * 1978-01-03 1978-11-07 Pfizer Inc. 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
US4133950A (en) * 1978-01-03 1979-01-09 Pfizer Inc. 4"-Deoxy-4"-carbamate and dithiocarbamate derivatives of oleandomycin and its esters
US4363803A (en) * 1982-03-01 1982-12-14 Pfizer Inc. 3",4"-Oxyallylene erythromycin and oleandomycin, composition and method of use
US4413119A (en) * 1982-03-01 1983-11-01 Pfizer Inc. Semi-synthetic macrolides
JPH0240447U (ja) * 1988-09-14 1990-03-19
US5141926A (en) * 1990-04-18 1992-08-25 Abbott Laboratories Erythromycin derivatives
JPH05155896A (ja) * 1991-01-18 1993-06-22 Yamanouchi Pharmaceut Co Ltd 新規マクロライド化合物及びその製造法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3022219A (en) * 1958-03-07 1962-02-20 Pfizer & Co C Acyl esters of oleandomycin
US3179652A (en) * 1961-09-05 1965-04-20 Pfizer & Co C Antibiotic recovery process and salts produced thereby
US3836519A (en) * 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin
US3842069A (en) * 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives
US4036853A (en) * 1976-08-06 1977-07-19 Pfizer Inc. Semi-synthetic oleandomycin derivatives-C8 modifications

Also Published As

Publication number Publication date
BG32117A4 (en) 1982-05-14
NL7801259A (nl) 1978-08-08
FR2383964B1 (ja) 1981-11-27
HU179744B (en) 1982-12-28
CS200537B2 (en) 1980-09-15
IE780240L (en) 1978-08-04
YU39517B (en) 1984-12-31
JPS5652036B2 (ja) 1981-12-09
SE7800269L (sv) 1978-08-05
FI780355A (fi) 1978-08-05
SE8300869D0 (sv) 1983-02-16
NO145955C (no) 1982-06-30
YU39504B (en) 1984-12-31
PL110793B1 (en) 1980-07-31
ATA72078A (de) 1980-01-15
AT358169B (de) 1980-08-25
JPS56135497A (en) 1981-10-22
FR2396022A1 (fr) 1979-01-26
FI65262C (fi) 1984-04-10
NO145955B (no) 1982-03-22
RO75387A (ro) 1980-11-30
JPS5398981A (en) 1978-08-29
US4125705A (en) 1978-11-14
NL175997C (nl) 1985-02-01
PT67569A (en) 1978-02-01
DE2804509A1 (de) 1978-08-10
PT67569B (en) 1979-06-18
FI65262B (fi) 1983-12-30
PH14836A (en) 1981-12-16
FR2396022B1 (ja) 1980-06-13
SE445222B (sv) 1986-06-09
CS200538B2 (en) 1980-09-15
DE2804509C2 (de) 1982-12-02
NO150439C (no) 1984-10-17
SU805949A3 (ru) 1981-02-15
ES465322A1 (es) 1978-09-16
YU151782A (en) 1982-10-31
PL113163B1 (en) 1980-11-29
SE457085B (sv) 1988-11-28
NO150439B (no) 1984-07-09
JPS5827799B2 (ja) 1983-06-11
HU181395B (en) 1983-07-28
NO811914L (no) 1978-08-07
GR68692B (ja) 1982-02-01
YU300377A (en) 1982-10-31
IL61606A0 (en) 1981-01-30
RO79264A (ro) 1982-06-25
ZA78646B (en) 1978-12-27
YU39518B (en) 1984-12-31
DD134523A5 (de) 1979-03-07
CA1106366A (en) 1981-08-04
DK149628C (da) 1987-02-02
IE46395B1 (en) 1983-06-01
PH16491A (en) 1983-10-28
AR215666A1 (es) 1979-10-31
IT7820006A0 (it) 1978-02-03
YU151882A (en) 1982-10-31
CH629821A5 (fr) 1982-05-14
FR2383964A1 (fr) 1978-10-13
DK149628B (da) 1986-08-18
RO79258A (ro) 1982-06-25
BE863618A (fr) 1978-08-03
SU1020004A3 (ru) 1983-05-23
IL53959A0 (en) 1978-04-30
PL111160B1 (en) 1980-08-30
SU888824A3 (ru) 1981-12-07
GB1583921A (en) 1981-02-04
NO780390L (no) 1978-08-07
AU502293B1 (en) 1979-07-19
IT1094211B (it) 1985-07-26
NZ186384A (en) 1980-08-26
LU79007A1 (fr) 1979-09-06
NL175997B (nl) 1984-09-03
DK51778A (da) 1978-08-05
PL204041A1 (pl) 1979-06-04
BG32116A3 (en) 1982-05-14

Similar Documents

Publication Publication Date Title
US4512982A (en) 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
KR850000965B1 (ko) 4"-에피 에리스로마이신 a 및 그의 유도체의 제조방법
FI72322B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara marolider
DE2804508C2 (de) Epimere 4"-substituierte Aminoderivate des Oleandomycins und deren Verwendung als antibakterielle Wirkstoffe
US4382086A (en) 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
JPS5827800B2 (ja) 新規抗菌剤
CS200536B2 (en) Method of producing epimeric 4-amino oleandomycin derivatives
FR2465743A1 (fr) Nouveaux derives 2-substitues de desoxy-2 fortimicines a et b, utiles notamment comme medicaments antibiotiques, et intermediaires et procede de leur preparation
US4585759A (en) Antibacterial derivatives of a neutral macrolide
EP0114486B1 (en) Alkylation of oleandomycin
US4283527A (en) Erythromycylamine 11,12-carbonate and derivatives thereof
AU616316B2 (en) New tylosin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
GB1585315A (en) Erythromycin a derivatives
US5374711A (en) Chemical modification of 2"-amino group in elsamicin a
FI66879B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara olandomycinderivat
CH661513A5 (de) 14-de-(hydroxymethyl)-mycaminosyltylonolid-verbindungen.
US5237055A (en) Chemical modification of 2"-amino group in elsamicin A
KR820001218B1 (ko) 반합성 4"-아미노-올레안도 마이신 유도체의 제조방법
FI68404C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4"deoxi-4"-aminoerytromycin-a-derivat
CS199728B2 (en) Method of producing derivatives of 4"-sulphonyl amino oleandomycin
KR820001126B1 (ko) 4-스펙티노마이실아민의 제조방법
KR820000742B1 (ko) 올레안도 마이신의 4"-데옥시-4"-아릴글리옥사미도 및 아로일티오포름아미도 유도체와 그의 에스테르의 제법
FR2524885A1 (fr) Nouveaux derives de 3-amino-3-demethoxyfortimicines et nouveaux medicaments antibiotiques les contenant
DE3012132A1 (de) 1-epi-fortimicin a und derivate dieser verbindung
IE46181B1 (en) Oleandomycin derivatives